Related Experiment Videos
Efficacy of pefloxacin-fosfomycin in experimental endocarditis caused by methicillin-resistant Staphylococcus aureus
C Thauvin1, J F Lemeland, G Humbert
1Department of Bacteriology, Centre Hospitalier Universitaire de Rouen, Institut National de la Santé et de la Recherche Médicale, France.
Abstract:
The efficacies of pefloxacin, fosfomycin, and both of these agents in combination against methicillin-resistant Staphylococcus aureus were assessed in a rat endocarditis model. The combination prevented emergence of the fosfomycin and pefloxacin resistance seen in 36 and 4%, respectively, of animals receiving either agent alone and was more effective than either agent in sterilizing cardiac vegetations.
Insights
The combination of pefloxacin and fosfomycin effectively treated methicillin-resistant Staphylococcus aureus endocarditis in rats. This combination prevented antibiotic resistance and sterilized cardiac vegetations better than single agents.
Area of Science:
- Infectious Diseases
- Pharmacology
- Microbiology
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant threat due to its resistance to common antibiotics.
- Endocarditis is a serious infection of the heart lining, often caused by Staphylococcus aureus.
Purpose of the Study:
- To evaluate the efficacy of pefloxacin, fosfomycin, and their combination against MRSA in a rat endocarditis model.
- To assess the impact of combination therapy on the emergence of antibiotic resistance.
Main Methods:
- A rat model of endocarditis was utilized to simulate human infection.
- Animals were treated with pefloxacin alone, fosfomycin alone, or a combination of both agents.
- Bacterial load in cardiac vegetations was quantified to assess sterilization efficacy.
Main Results:
- The combination therapy was more effective in sterilizing cardiac vegetations compared to monotherapy.
- Pefloxacin monotherapy led to resistance in 4% of animals, while fosfomycin monotherapy resulted in resistance in 36%.
- The combination regimen prevented the emergence of resistance to either antibiotic.
Conclusions:
- Combination therapy with pefloxacin and fosfomycin is a promising strategy for treating MRSA endocarditis.
- This combination overcomes the limitations of monotherapy by enhancing efficacy and preventing resistance development.